ethambutol has been researched along with Hypoxia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Luukinen, H; Myllymäki, H; Niskanen, M; Parikka, M; Rämet, M | 1 |
Fattorini, L; Giannoni, F; Iacobino, A; Pardini, M; Piccaro, G | 1 |
2 other study(ies) available for ethambutol and Hypoxia
Article | Year |
---|---|
Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.
Topics: Animals; Antigens, Bacterial; Bacterial Load; Biomarkers; Dexamethasone; Disease Models, Animal; Ethambutol; Granuloma; Hypoxia; Immunosuppression Therapy; Lymphocyte Depletion; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; T-Lymphocytes; Tuberculosis Vaccines; Zebrafish | 2018 |
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Topics: Antitubercular Agents; Drug Combinations; Drug Therapy, Combination; Ethambutol; Humans; Hydrogen-Ion Concentration; Hypoxia; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis | 2019 |